321 related articles for article (PubMed ID: 35695714)
21. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
Sala M; Diab R; Elaissari A; Fessi H
Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
[TBL] [Abstract][Full Text] [Related]
22. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties.
Touitou E; Dayan N; Bergelson L; Godin B; Eliaz M
J Control Release; 2000 Apr; 65(3):403-18. PubMed ID: 10699298
[TBL] [Abstract][Full Text] [Related]
23. Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery.
Ita K
Curr Pharm Des; 2016; 22(33):5120-5126. PubMed ID: 27165164
[TBL] [Abstract][Full Text] [Related]
24. Recent Developments in the Principles, Modification and Application Prospects of Functionalized Ethosomes for Topical Delivery.
Lu J; Guo T; Fan Y; Li Z; He Z; Yin S; Feng N
Curr Drug Deliv; 2021; 18(5):570-582. PubMed ID: 32851961
[TBL] [Abstract][Full Text] [Related]
25. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Sharma G; Goyal H; Thakur K; Raza K; Katare OP
Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
[TBL] [Abstract][Full Text] [Related]
26. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
[TBL] [Abstract][Full Text] [Related]
27. Vesicular system: Versatile carrier for transdermal delivery of bioactives.
Singh D; Pradhan M; Nag M; Singh MR
Artif Cells Nanomed Biotechnol; 2015; 43(4):282-90. PubMed ID: 24564350
[TBL] [Abstract][Full Text] [Related]
28. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
[TBL] [Abstract][Full Text] [Related]
29. Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials.
Abdulbaqi IM; Darwis Y; Khan NA; Assi RA; Khan AA
Int J Nanomedicine; 2016; 11():2279-304. PubMed ID: 27307730
[TBL] [Abstract][Full Text] [Related]
30. Transethosome: An ultra-deformable ethanolic vesicle for enhanced transdermal drug delivery.
Raj A; Dua K; Nair RS; Sarath Chandran C; Alex AT
Chem Phys Lipids; 2023 Sep; 255():105315. PubMed ID: 37356610
[TBL] [Abstract][Full Text] [Related]
31. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes.
Shen LN; Zhang YT; Wang Q; Xu L; Feng NP
Int J Pharm; 2014 Jan; 460(1-2):280-8. PubMed ID: 24269286
[TBL] [Abstract][Full Text] [Related]
32. Ethosomal Gel for Improving Transdermal Delivery of Thymosin β-4.
Fu X; Shi Y; Wang H; Zhao X; Sun Q; Huang Y; Qi T; Lin G
Int J Nanomedicine; 2019; 14():9275-9284. PubMed ID: 31819429
[TBL] [Abstract][Full Text] [Related]
33. Transdermal delivery from liposomal formulations - Evolution of the technology over the last three decades.
Ashtikar M; Nagarsekar K; Fahr A
J Control Release; 2016 Nov; 242():126-140. PubMed ID: 27620074
[TBL] [Abstract][Full Text] [Related]
34. Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties.
Zhai Y; Xu R; Wang Y; Liu J; Wang Z; Zhai G
J Liposome Res; 2015; 25(4):316-24. PubMed ID: 25625544
[TBL] [Abstract][Full Text] [Related]
35. Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus.
Mbah CC; Builders PF; Attama AA
Expert Opin Drug Deliv; 2014 Jan; 11(1):45-59. PubMed ID: 24294974
[TBL] [Abstract][Full Text] [Related]
36. Nano-Formulation Approaches to Enhance Transdermal Drug Delivery-An Updated Review of Nanovesicular Carrier "Transethosomes".
Singh JP; Saini G; Tiwari G; Singh B
Pharm Nanotechnol; 2024 May; ():. PubMed ID: 38757163
[TBL] [Abstract][Full Text] [Related]
37. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.
Jain S; Tiwary AK; Sapra B; Jain NK
AAPS PharmSciTech; 2007 Dec; 8(4):E111. PubMed ID: 18181532
[TBL] [Abstract][Full Text] [Related]
38. Development of curcumin-loaded composite phospholipid ethosomes for enhanced skin permeability and vesicle stability.
Li Y; Xu F; Li X; Chen SY; Huang LY; Bian YY; Wang J; Shu YT; Yan GJ; Dong J; Yin SP; Gu W; Chen J
Int J Pharm; 2021 Jan; 592():119936. PubMed ID: 33038455
[TBL] [Abstract][Full Text] [Related]
39. Unlocking the potential of cosmetic dermal delivery with ethosomes: A comprehensive review.
Abu-Huwaij R; Zidan AN
J Cosmet Dermatol; 2024 Jan; 23(1):17-26. PubMed ID: 37393573
[TBL] [Abstract][Full Text] [Related]
40. What's new in the field of phospholipid vesicular nanocarriers for skin drug delivery.
Lai F; Caddeo C; Manca ML; Manconi M; Sinico C; Fadda AM
Int J Pharm; 2020 Jun; 583():119398. PubMed ID: 32376441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
